These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 22201077

  • 1. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
    Kristesashvili J, Chanukvadze D.
    Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of different diagnostic methods for assessment of hyperandrogenism in young women with hirsutism.
    Chanukvadze D, Kristesashvili J.
    Georgian Med News; 2011 Nov; 11(200):25-9. PubMed ID: 22201076
    [Abstract] [Full Text] [Related]

  • 3. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S, Dittrich R, Binder H, Kajaia N, Hoffmann I, Maltaris T, Beckmann MW, Mueller A.
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [Abstract] [Full Text] [Related]

  • 4. Hyperandrogenism in oligomenorrhoea with minimal or nil 'unwanted hair growth'.
    Bhattacharya SM.
    Gynecol Endocrinol; 2009 Jul; 25(7):423-6. PubMed ID: 19499416
    [Abstract] [Full Text] [Related]

  • 5. Endocrinological markers for assessment of hyperandrogenemia in hirsute women.
    Mueller A, Cupisti S, Binder H, Hoffmann I, Kiesewetter F, Beckmann MW, Dittrich R.
    Horm Res; 2007 Jul; 67(1):35-41. PubMed ID: 17019078
    [Abstract] [Full Text] [Related]

  • 6. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
    Hassa H, Tanir HM, Yildiz Z.
    Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
    [Abstract] [Full Text] [Related]

  • 7. [Exploration of the classification of polycystic ovarian syndrome].
    Lin JF, Li X, Zhu MW.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
    [Abstract] [Full Text] [Related]

  • 8. Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism.
    Ozdemir S, Ozdemir M, Görkemli H, Kiyici A, Bodur S.
    Acta Obstet Gynecol Scand; 2010 Oct; 89(2):199-204. PubMed ID: 19900078
    [Abstract] [Full Text] [Related]

  • 9. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
    Mueller A, Dittrich R, Cupisti S, Beckmann MW, Binder H.
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance and androgens in healthy women with different body fat distributions.
    Ivandić A, Prpić-Krizevac I, Bozić D, Barbir A, Peljhan V, Balog Z, Glasnović M.
    Wien Klin Wochenschr; 2002 May 15; 114(8-9):321-6. PubMed ID: 12212367
    [Abstract] [Full Text] [Related]

  • 11. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.
    Medicine (Baltimore); 2009 Jan 15; 88(1):32-45. PubMed ID: 19352298
    [Abstract] [Full Text] [Related]

  • 12. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
    Pavičić Baldani D, Škrgatić L, Bukvić Mokos Z, Trgovčić I.
    Acta Dermatovenerol Croat; 2013 Jan 15; 21(2):105-12. PubMed ID: 24001418
    [Abstract] [Full Text] [Related]

  • 13. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
    Mesch VR, Siseles NO, Maidana PN, Boero LE, Sayegh F, Prada M, Royer M, Schreier L, Benencia HJ, Berg GA.
    Climacteric; 2008 Jan 15; 11(6):509-17. PubMed ID: 18991078
    [Abstract] [Full Text] [Related]

  • 14. [Female hyperandrogenemia and normal serum levels of testosterone and sex hormone binding globulin].
    Danilowicz K, Bruno OD, Mana D, Serra HA, Cross G, Rey JA.
    Medicina (B Aires); 2014 Jan 15; 74(5):359-62. PubMed ID: 25347896
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of androgens in women with adult-onset acne.
    Seirafi H, Farnaghi F, Vasheghani-Farahani A, Alirezaie NS, Esfahanian F, Firooz A, Ghodsi SZ.
    Int J Dermatol; 2007 Nov 15; 46(11):1188-91. PubMed ID: 17988341
    [Abstract] [Full Text] [Related]

  • 17. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
    Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM.
    Nutr Res; 2011 Feb 15; 31(2):97-103. PubMed ID: 21419313
    [Abstract] [Full Text] [Related]

  • 18. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W.
    J Cosmet Dermatol; 2018 Jun 15; 17(3):511-517. PubMed ID: 28940857
    [Abstract] [Full Text] [Related]

  • 19. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb 15; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 20. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Feb 15; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.